Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional, Observational Study Evaluating Changes in Drug Load and Seizure Frequency Using Vimpat (Lacosamide) in Daily Clinical Practice in Combination Therapy With Sodium Channel Blocking Anti-epileptic Drugs (AEDs) or Non Sodium Channel Blocking AEDs

NCT01673282 is registered in ClinicalTrials.gov with UCB Pharma GmbH as lead sponsor.

NCT NCT01673282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01673282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional, Observational Study Evaluating Changes in Drug Load and Seizure Frequency Using Vimpat (Lacosamide) in Daily Clinical Practice in Combination Therapy With Sodium Channel Blocking Anti-epileptic Drugs (AEDs) or Non Sodium Channel Blocking AEDs
Lead sponsor
UCB Pharma GmbH
Phase
Observational
Overall status
Completed
Start date
July 31, 2012
Completion date
July 31, 2015
Enrollment
315 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

focal epilepsy with and without secondary generalization